StockData

VitaSpring Biomedical Co. Ltd. (VSBC) stock

VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 17, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $6.58MP/E –Yield –

VitaSpring Biomedical revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

VitaSpring Biomedical's revenue for the twelve months ending Jul 31, 2026 was $0. For fiscal 2026 it was $0. The highest annual figure on record is $5.61M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2026Jan 31, 2026$0–
FY2025Jan 31, 2025$0–
FY2024Jan 31, 2024$0–
FY2023Jan 31, 2023$0-100.0%
FY2022Jan 31, 2022$5.61M+2161.6%
FY2021Jan 31, 2021$248.20K+1539.4%
FY2020Jan 31, 2020$15.14K-11.9%
FY2019Jan 31, 2019$17.18K+5.9%
FY2018Jan 31, 2018$16.23K–
FY2017Jan 31, 2017$0–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2027CQ2 2026Jul 31, 2026$0–
Q1 FY2027CQ1 2026Apr 30, 2026$0–
Q4 FY2026CQ4 2025Jan 31, 2026$0–
Q3 FY2026CQ3 2025Oct 31, 2025$0–
Q2 FY2026CQ2 2025Jul 31, 2025$0–
Q1 FY2026CQ1 2025Apr 30, 2025$0–
Q4 FY2025CQ4 2024Jan 31, 2025$0–
Q3 FY2025CQ3 2024Oct 31, 2024$0–
Q2 FY2025CQ2 2024Jul 31, 2024$0–
Q1 FY2025CQ1 2024Apr 30, 2024$0–
Q4 FY2024CQ4 2023Jan 31, 2024$0–
Q3 FY2024CQ3 2023Oct 31, 2023$0–
Q2 FY2024CQ2 2023Jul 31, 2023$0-100.0%
Q1 FY2024CQ1 2023Apr 30, 2023$0-100.0%
Q3 FY2023CQ3 2022Oct 31, 2022$0-100.0%
Q2 FY2023CQ2 2022Jul 31, 2022$0-100.0%
Q1 FY2023CQ1 2022Apr 30, 2022$1.49M+179.1%
Q4 FY2022CQ4 2021Jan 31, 2022$3.49M+1305.7%
Q3 FY2022CQ3 2021Oct 31, 2021$200.00K–
Q2 FY2022CQ2 2021Jul 31, 2021$1.39M–
Q1 FY2022CQ1 2021Apr 30, 2021$533.80K–
Q4 FY2021CQ4 2020Jan 31, 2021$248.20K+6183.5%
Q3 FY2021CQ3 2020Oct 31, 2020$0–
Q2 FY2021CQ2 2020Jul 31, 2020$0–
Q1 FY2021CQ1 2020Apr 30, 2020$0-100.0%
Q4 FY2020CQ4 2019Jan 31, 2020$3.95K+48.8%
Q3 FY2020CQ3 2019Oct 31, 2019$0-100.0%
Q2 FY2020CQ2 2019Jul 31, 2019$0-100.0%
Q1 FY2020CQ1 2019Apr 30, 2019$7.22K-42.0%
Q4 FY2019CQ4 2018Jan 31, 2019$2.66K+60.9%
Q3 FY2019CQ3 2018Oct 31, 2018$75-97.8%
Q2 FY2019CQ2 2018Jul 31, 2018$2.00K-60.0%
Q1 FY2019CQ1 2018Apr 30, 2018$12.45K+103.4%
Q4 FY2018CQ4 2017Jan 31, 2018$1.65K–
Q3 FY2018CQ3 2017Oct 31, 2017$3.46K–
Q2 FY2018CQ2 2017Jul 31, 2017$5.00K–
Q1 FY2018CQ1 2017Apr 30, 2017$6.12K–

More VitaSpring Biomedical figures

See a number that looks wrong?